Liu, R., Ji, Z., Wang, X., Xin, J., Zhu, L., Ge, S., . . . Ba, Y. (2025). Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancer. Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies, 43(1), 81-92. https://doi.org/10.1007/s10637-024-01485-5
Chicago-referens (17:e uppl.)Liu, Rui, et al. "Efficacy and Safety of Multi-target Tyrosine Kinase Inhibitor AL2846 Combined with Gemcitabine in Pancreatic Cancer." Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies 43, no. 1 (2025): 81-92. https://doi.org/10.1007/s10637-024-01485-5.
MLA-referens (9:e uppl.)Liu, Rui, et al. "Efficacy and Safety of Multi-target Tyrosine Kinase Inhibitor AL2846 Combined with Gemcitabine in Pancreatic Cancer." Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies, vol. 43, no. 1, 2025, pp. 81-92, https://doi.org/10.1007/s10637-024-01485-5.
